COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,790 Articles (22,523 medRxiv, 8,267 bioRxiv)

Most recent first Previous |  Page 372: Articles 3711-3720  | Next

Distinct T cell functional profiles in SARS-CoV-2 seropositive and seronegative children associated with endemic human coronavirus cross-reactivity
Benede, N. S. B., Tincho, M. B., Walters, A., Subbiah, V., Ngomti, A., Baguma, R., Butters, C., Mennen, M., Skelem, S., Adriaanse, M., van Graan, S., Balla, S. R., Moyo-Gwete, T., Moore, P. L., Botha, M., Workman, L., Zar, H. J., Ntusi, N. A. B., Zühlke, L., Webb, K., Riou, C., Burgers, W. A., Keeton, R. S.
10.1101/2023.05.16.23290059 — Posted: 2023-05-23
Wastewater-based reproduction numbers and projections of COVID-19 cases in multiple cities in Japan, 2022
Miyazawa, S., Wong, T., Ito, G., Iwamoto, R., Watanabe, K., van Boven, M., Wallinga, J., Miura, F.
10.1101/2023.05.22.23290332 — Posted: 2023-05-23
Pandemic Lessons of Sustainability: Higher Covid-19 Mortality in Less Sustainable US States
LIU, L. n.
10.1101/2023.05.22.23290349 — Posted: 2023-05-23
Vaccine-mediated protection against merbecovirus and sarbecovirus challenge in mice
Martinez, D., Schaefer, A. R., Gavitt, T., Mallory, M., Lee, E., Catanzaro, N., Chen, H., Gully, K., Scobey, T. D., Korategere, P., Brown, A., Smith, L., Parks, R., Barr, M., Newman, A., Bowman, C., Powers, J. M., Mansouri, K., Edwards, R. J., Baric, R. S., Haynes, B., Saunders, K. O.
10.1101/2023.05.22.540829 — Posted: 2023-05-23
Markov State Models and Perturbation-Based Approaches Reveal Distinct Dynamic Signatures and Hidden Allosteric Pockets in the Emerging SARS-Cov-2 Spike Omicron Variants Complexes with the Host Receptor: The Interplay of Dynamics and Convergent Evolution Modulates Allostery and Functional Mechanisms
Xiao, S., Alshahrani, M., Gupta, G., Tao, P., Verkhivker, G.
10.1101/2023.05.20.541592 — Posted: 2023-05-22
An Atlas of Adaptive Evolution in Endemic Human Viruses
Kistler, K., Bedford, T.
10.1101/2023.05.19.541367 — Posted: 2023-05-22
Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian Hamsters
Garcia-Bernalt Diego, J., Singh, G., Jangra, S., Handrejk, K., Laporte, M., Chang, L. A., El Zahed, S. S., Pache, L., Chang, M. W., Warang, P., Aslam, S., Mena, I., Webb, B. T., Benner, C., Garcia-Sastre, A., Schotsaert, M.
10.1101/2023.05.22.541294 — Posted: 2023-05-22
The COVID-19 mRNA vaccine Comirnaty induces anaphylactic shock in an anti-PEG hyperimmune large animal model: Role of complement in cardiovascular, hematological, and inflammatory mediator changes
Barta, B. A., Radovits, T., Dobos, A. B., Kozma, G. T., Meszaros, T., Berenyi, P., Facsko, R., Fulop, T. G., Merkely, B., Szebeni, J.
10.1101/2023.05.19.541479 — Posted: 2023-05-22
Contrasting the open access dissemination of COVID-19 and SDG research
Lariviere, V., Basson, I., Clack, J.
10.1101/2023.05.18.541286 — Posted: 2023-05-21
Impact of the COVID-19 pandemic on low back pain management in commercially insured and Medicare Advantage cohorts. A retrospective cohort study
Elton, D., Zhang, M.
10.1101/2023.05.15.23289993 — Posted: 2023-05-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).